Allderma
Allderma AB is a Stockholm-based, privately held Swedish company founded in 2001 that distributes OTC pharmaceutical products focused on dermatological health, including innovative topical treatments such as MOB-015.
- Company typePrivate
- Founded2001
- HeadquartersStockholm, Sweden
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Allderma does
Allderma AB is a privately held Swedish over-the-counter pharmaceutical distributor headquartered in Stockholm and founded in 2001. The company focuses on dermatological health and carries a portfolio that includes innovative topical treatments such as MOB-015, a product associated with the treatment of nail and skin conditions. Operationally, Allderma functions as a specialty OTC distributor rather than a discovery-stage originator; its scope of activity covers Sweden with potential Nordic reach, although the precise geographic footprint is not quantified in the available data.
The firm's scale is modest — between 11 and 50 employees — consistent with a focused marketing-and-distribution model built around a small set of dermatology assets. The product mix signals a deliberate tilt toward branded, clinically differentiated topical therapeutics rather than generic skin care, with MOB-015 as the named flagship. Underlying technology details (formulation, delivery technology, regulatory dossiers) are not disclosed in the input; the company is therefore best characterized as a distribution and commercialization vehicle for dermatology IP sourced from or shared with development partners.
Allderma's revenue mechanics are not disclosed in the source material. As an OTC distributor, the most plausible model is unit-based wholesale and/or pharmacy-channel revenue on branded dermatology SKUs, with margins set by Swedish pharmacy procurement dynamics and tendering. No pricing structure, customer list, distribution contract terms, or partnership agreements are available in the input, which materially constrains revenue visibility for an investor audience.
Allderma firmographics
Firmographics- Name
- Allderma
- Website
- https://allderma.se
- Company type
- Private
- Founded year
- 2001
- Headcount range
- 11–50 employees
- Short description
- Allderma AB is a Stockholm-based, privately held Swedish company founded in 2001 that distributes OTC pharmaceutical products focused on dermatological health, including innovative topical treatments such as MOB-015.
- Ownership category
- akta.pro rank
Allderma industry classification
Industry- Product category
- OTC Pharmaceutical Distribution (Dermatology)
- NAICS
- Drugs and Druggists' Sundries Merchant Wholesalers (42421)
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Dermatology & Topical Skin Treatments (HLAIADAE)
- akta.pro secondary industries
- OTC Medicines & Consumer Health Products Distribution (CRAOAHAB), OTC & Consumer Health Distributors (HLAIAJAC)
Keywords
Where Allderma is headquartered
LocationHeadquarters
- HQ city
- Stockholm
- HQ country
- Sweden
- HQ region
- Europe
Markets served
Allderma business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Supply Chain, Personnel, Operations, Marketing or Sales
Allderma product offering
Product offeringCore offering
Allderma AB distributes over-the-counter (OTC) pharmaceuticals with a focus on dermatological health, supplying innovative treatments such as MOB-015 to pharmacy and healthcare retail channels. The company acts as a specialized distributor, curating and delivering skin-health products to resellers and end consumers via Sweden-based operations.
Differentiator
Problem solved
Functional benefit
Companies that use Allderma
Customer profileIdeal customer profiles1 record
Allderma technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Allderma partnerships and signals
Strategic signalRecent moves2 records
Expansion highlights3 records
Allderma competitors and assessment
Company assessmentOthers
Broad incumbents
- STADA Arzneimittel: Large European generics and OTC company with significant dermatology and consumer health portfolio; comparable as a broad incumbent supplying similar product categories across European pharmacy channels.
- Bayer Consumer Health: Global consumer health division of Bayer with a large dermatology and skin care OTC portfolio; comparable as a broad incumbent in adjacent OTC categories.
- Perrigo Company: Major global OTC consumer healthcare company; a broad incumbent whose dermatology and skin health products compete in the same categories Allderma distributes.
- LEO Pharma: Global dermatology-focused pharma company headquartered in Denmark; competes broadly in the same dermatology prescription and OTC categories Allderma serves.
Emerging players
- Almirall: European specialty pharma focused on dermatology; an emerging player with meaningful overlap in dermatology categories, though more prescription-leaning than Allderma.
Direct peers
- Orifarm: Danish-headquartered parallel importer and OTC/generics distributor serving Nordic and European pharmacy markets; comparable as a regional OTC distribution platform of similar scale.
- Moberg Pharma: Swedish specialty pharma company that developed MOB-015 for nail fungus; a key partner/principal supplier to Allderma, operating in the same dermatology OTC niche.
- Karo Healthcare: Nordic OTC pharmaceutical company with strong presence in dermatology and consumer health brands across Scandinavia; directly comparable as a regional OTC distributor/brand owner targeting similar pharmacy channels.
Regional players
- Meda (now part of Viatris/Mylan): Historically a major Nordic OTC and specialty pharma company (now part of Viatris); comparable historically as a Stockholm-rooted OTC player of similar geographic orientation.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights5 records
Customer concentration
Allderma social profiles
Digital presenceAllderma financial estimates
Financial estimateRevenue estimate
Valuation estimate
Allderma leadership team
Management profileNumber of profiles
Profiles1 record
Allderma funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Allderma M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Allderma
What does Allderma do?
Allderma AB distributes over-the-counter (OTC) pharmaceuticals with a focus on dermatological health, supplying innovative treatments such as MOB-015 to pharmacy and healthcare retail channels. The company acts as a specialized distributor, curating and delivering skin-health products to resellers and end consumers via Sweden-based operations.
When was Allderma founded?
Allderma was founded in 2001. It employs 11 to 50 people.
Where is Allderma based?
Allderma is headquartered in Stockholm, Sweden, in the Europe region.
Who are Allderma's main competitors?
Galderma is listed as an others. Broad incumbents are STADA Arzneimittel, Bayer Consumer Health, Perrigo Company and LEO Pharma. Almirall is listed as an emerging player. Direct peers are Orifarm, Moberg Pharma and Karo Healthcare. Meda (now part of Viatris/Mylan) is listed as a regional player.
Does Allderma have an API?
No public API is recorded for Allderma.
What industry is Allderma in?
Allderma's product category is OTC Pharmaceutical Distribution (Dermatology). Its primary akta.pro industry code is HLAIADAE, Dermatology & Topical Skin Treatments, with a secondary code of CRAOAHAB, OTC Medicines & Consumer Health Products Distribution. Its NAICS code is 42421 and its SIC code is 5122.